{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:02:24Z","timestamp":1761897744315,"version":"build-2065373602"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12029-025-01340-7","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:54:12Z","timestamp":1761893652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Higher Risk of Liver Cancer in Alcoholic Fatty Liver Disease than in Non-Alcoholic Fatty Liver Disease: an Analysis of the TriNetX Dabatase"],"prefix":"10.1007","volume":"56","author":[{"given":"Ling-Hui","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-You","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Yu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"4","key":"1340_CR1","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/MEG.0000000000002899","volume":"37","author":"Q Wang","year":"2025","unstructured":"Wang Q, Jia W, Liu J, Zhao Q, Yang Z. Global, regional, and national burden of liver cancer due to alcohol use, 1990\u20132021: results from the global burden of disease study 2021. Eur J Gastroenterol Hepatol. 2025;37(4):466\u201376.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"1340_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3350\/cmh.2024.0835","volume":"31","author":"P Danpanichkul","year":"2025","unstructured":"Danpanichkul P, D\u00edaz LA, Suparan K, Tothanarungroj P, Sirimangklanurak S, Auttapracha T, et al. Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000\u20132021. Clin Mol Hepatol. 2025;31(2):525\u201347.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"1340_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/acer.15516","volume":"49","author":"P Danpanichkul","year":"2025","unstructured":"Danpanichkul P, Duangsonk K, Tham EKJ, Tothanarungroj P, Auttapracha T, Prasitsumrit V, et al. Increased mortality from alcohol use disorder, alcohol-associated liver disease, and liver cancer from alcohol among older adults in the United states: 2000 to 2021. Alcohol Clin Exp Res. 2025;49(2):368\u201378.","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"1340_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17040609","volume":"17","author":"P Danpanichkul","year":"2025","unstructured":"Danpanichkul P, Pang Y, Diaz LA, Arab JP, Hwang SY, Dejvajara D, et al. Young adults and alcohol-associated liver cancer: incidence and death from 2000 to 2021. Cancers (Basel). 2025;17(4):609.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"1340_CR5","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","volume":"155","author":"F Kanwal","year":"2018","unstructured":"Kanwal F, Kramer JR, Mapakshi S, Natarajan Y, Chayanupatkul M, Richardson PA, et al. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology. 2018;155(6):1828\u2013e18372.","journal-title":"Gastroenterology"},{"issue":"3","key":"1340_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s12072-025-10782-x","volume":"19","author":"T Yang","year":"2025","unstructured":"Yang T, Lei Y, Liao L, Xie C, Mo X, Cai D, et al. Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, 1990\u20132021: a multi-model trend analysis and forecasting study. Hepatol Int. 2025;19(3):619\u201332.","journal-title":"Hepatol Int"},{"key":"1340_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.puhe.2025.02.028","volume":"242","author":"Y Gu","year":"2025","unstructured":"Gu Y, Guo C, Liu Z, Zhang Y, Han X, Zhang X, et al. The trend in incidence of non-alcoholic fatty liver disease and its impact on cirrhosis and liver cancer: an analysis from global burden of disease 2021. Public Health. 2025;242:79\u201386.","journal-title":"Public Health"},{"issue":"33","key":"1340_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026982","volume":"100","author":"F He","year":"2021","unstructured":"He F, Sha Y, Wang B. Relationship between alcohol consumption and the risks of liver cancer, esophageal cancer, and gastric cancer in China: meta-analysis based on case-control studies. Medicine. 2021;100(33):e26982.","journal-title":"Medicine"},{"issue":"8","key":"1340_CR9","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/annonc\/mdu020","volume":"25","author":"F Turati","year":"2014","unstructured":"Turati F, Galeone C, Rota M, Pelucchi C, Negri E, Bagnardi V, et al. Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies. Ann Oncol. 2014;25(8):1526\u201335.","journal-title":"Ann Oncol"},{"issue":"9","key":"1340_CR10","first-page":"1205","volume":"26","author":"SC Chuang","year":"2015","unstructured":"Chuang SC, Lee YC, Wu GJ, Straif K, Hashibe M. Alcohol consumption and liver cancer risk: a meta-analysis. Cancer Causes Control. 2015;26(9):1205\u201331.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"1340_CR11","first-page":"195","volume":"35","author":"IH McKillop","year":"2005","unstructured":"McKillop IH, Schrum LW, Alcohol. Alcohol Liver Cancer. 2005;35(3):195\u2013203.","journal-title":"Alcohol Liver Cancer"},{"issue":"4","key":"1340_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.cld.2012.08.011","volume":"16","author":"P Grewal","year":"2012","unstructured":"Grewal P, Viswanathen VA. Liver cancer and alcohol. Clin Liver Dis. 2012;16(4):839\u201350.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"1340_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/a-2551-3320","volume":"45","author":"T Liu","year":"2025","unstructured":"Liu T, Zhang F, Feng Y, Han P, Gao Y. Alcohol-metabolizing enzymes, liver diseases and cancer. Semin Liver Dis. 2025;45(1):99\u2013113.","journal-title":"Semin Liver Dis"},{"key":"1340_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-446","volume":"11","author":"GA Heckley","year":"2011","unstructured":"Heckley GA, Jarl J, Asamoah BO, G-Gerdtham U. How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature. BMC Cancer. 2011;11:446.","journal-title":"BMC Cancer"},{"key":"1340_CR15","unstructured":"Kim GA, Lee HC, Choe J, Kim MJ, Lee MJ, Chang HS et al. Association between non-alcoholic fatty liver disease and cancer incidence rate. J Hepatol. 2017:S0168-8278(17)32294-8."},{"key":"1340_CR16","doi-asserted-by":"publisher","first-page":"100809","DOI":"10.1016\/j.neo.2022.100809","volume":"30","author":"F Petrelli","year":"2022","unstructured":"Petrelli F, Manara M, Colombo S, De Santi G, Ghidini M, Mariani M, et al. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and steatosis or steatohepatitis. Neoplasia. 2022;30:100809.","journal-title":"Neoplasia"},{"issue":"2","key":"1340_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","volume":"20","author":"LA Orci","year":"2022","unstructured":"Orci LA, Sanduzzi-Zamparelli M, Caballol B, Sapena V, Colucci N, Torres F, et al. Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review, meta-analysis, and meta-regression. Clin Gastroenterol Hepatol. 2022;20(2):283\u2013e29210.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"1340_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107612","volume":"34","author":"XJ Ge","year":"2020","unstructured":"Ge XJ, Du YX, Zheng LM, Wang M, Jiang JY. Mortality trends of liver cancer among patients with type 2 diabetes at the global and national level. J Diabetes Complications. 2020;34(8):107612.","journal-title":"J Diabetes Complications"},{"issue":"4","key":"1340_CR19","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/hep.30083","volume":"68","author":"Y Pang","year":"2018","unstructured":"Pang Y, Kartsonaki C, Turnbull I, Guo Y, Clarke R, Chen Y, et al. Diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: a prospective study of 0.5 million people. Hepatology. 2018;68(4):1308\u201318.","journal-title":"Hepatology"},{"issue":"5","key":"1340_CR20","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ijc.34965","volume":"155","author":"NT Ho","year":"2024","unstructured":"Ho NT, Abe SK, Rahman MS, Islam R, Saito E, Gupta PC, et al. Diabetes is associated with increased liver cancer incidence and mortality in adults: a report from Asia cohort consortium. Int J Cancer. 2024;155(5):854\u201370.","journal-title":"Int J Cancer"},{"key":"1340_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/15330338221119743","volume":"21","author":"SA Onikanni","year":"2022","unstructured":"Onikanni SA, Lawal B, Bakare OS, Ajiboye BO, Ojo OA, Farasani A, et al. Cancer of the liver and its relationship with diabetes mellitus. Technol Cancer Res Treat. 2022;21:15330338221119743.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"1340_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","volume":"71","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Schattenberg JM, et al. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut. 2022;71(1):156\u201362.","journal-title":"Gut"},{"issue":"7","key":"1340_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001680","volume":"11","author":"G Musso","year":"2014","unstructured":"Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014;11(7):e1001680.","journal-title":"PLoS Med"},{"issue":"14","key":"1340_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143617","volume":"13","author":"F Fabrizi","year":"2021","unstructured":"Fabrizi F, Cerutti R, Alfieri CM, Ridruejo E. An update on hepatocellular carcinoma in chronic kidney disease. Cancers (Basel). 2021;13(14):3617.","journal-title":"Cancers (Basel)"},{"issue":"9173","key":"1340_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","volume":"354","author":"P Maisonneuve","year":"1999","unstructured":"Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, et al. Cancer in patients on Dialysis for end-stage renal renal disease: an international collaborative study. Lancet. 1999;354(9173):93\u20139.","journal-title":"Lancet"},{"issue":"3","key":"1340_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s40620-020-00751-y","volume":"34","author":"M Kanbay","year":"2021","unstructured":"Kanbay M, Bulbul MC, Copur S, Afsar B, Sag AA, Siriopol D, et al. Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease. J Nephrol. 2021;34(3):649\u201359.","journal-title":"J Nephrol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01340-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01340-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:54:19Z","timestamp":1761893659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01340-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01340-7","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"18 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As the TriNetX database contains de-identified and anonymized patient information, this study was exempt from ethical approval and informed consent requirements. All research activities were conducted in strict accordance with applicable ethical standards and regulatory guidelines, consistent with the Declaration of Helsinki principles.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"211"}}